S. Schepartz

发表

Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials

M. Christian, L. Rubinstein, D. Zaharevitz, 2001, British Journal of Cancer.

The taxol supply crisis. New NCI policies for handling the large-scale production of novel natural product anticancer and anti-HIV agents.

M. Grever, S. Schepartz, G. Cragg, 1993, Journal of natural products.

The National Cancer Institute: cancer drug discovery and development program.

M R Grever, M. Grever, B. Chabner, 1992, Seminars in oncology.

Role of Plants in the National Cancer Institute Drug Discovery and Development Program

M. Grever, M. Boyd, S. Schepartz, 1994 .

Bacterial levans of intermediate molecular weight.

S. Schepartz, M. J. Johnson, C. E. Holmlund, 1955, Applied microbiology.

Screening data from the Cancer Chemotherapy National Service Center Screening Laboratories. XXI.

S. Schepartz, B. Abbott, J. Leiter, 1964, Cancer research. Supplement.

Use of arginine to eliminate medium changes in tissue culture systems.

S. Schepartz, W. F. Mclimans, W. Thomas, 1958, Science.

Screening data from the Cancer Chemotherapy National Service Center screening laboratories. X. Cell culture cytotoxicity tests.

S. Schepartz, J. Leiter, M. M. Macdonald, 1962, Cancer research.

Freezing and preservation of mouse tumor slices.

I. Kline, S. Schepartz, R. Trapani, 1962, Cancer chemotherapy reports.

Preservation and characterization of cultured cells and animal tumors.

I. Kline, S. Schepartz, R. Acker, 1962, Cancer chemotherapy reports.

Screening data from the Cancer Chemotherapy National Service Center screening laboratories. XL. Plant extracts.

S. Schepartz, B. Abbott, J. Hartwell, 1967, Cancer research.

Screening data from the Cancer Chemotherapy National Service Center screening laboratories. XXX. Plant extracts.

S. Schepartz, B. Abbott, J. Hartwell, 1966, Cancer research.

Screening data from the Cancer Chemotherapy National Service Center screening laboratories. XXXV.

S. Schepartz, B. Abbott, J. Leiter, 1966, Cancer research.

Pharmaceutical Prospecting and the Potential for Pharmaceutical Crops. Natural Product Drug Discovery and Development at the United States National Cancer Institute

M. Grever, M. Boyd, S. Schepartz, 1995 .

THE NATURE OF THE BINDING OF PENICILLIN BY BACTERIAL CELLS

S. Schepartz, M. J. Johnson, 1956, Journal of bacteriology.

US-NCI Testing Procedures

E. Sausville, J. Plowman, M. Alley, 1999 .

Summary of the workshop on Drug Development, Biological Diversity, and Economic Growth.

M. Grever, S. Schepartz, G. Cragg, 1991, Journal of the National Cancer Institute.

Orphan products activities of the National Institutes of Health.

S. Schepartz, 1983, Progress in clinical and biological research.

Historical background of the National Cancer Institute's drug development thrust.

S. Carter, S. Schepartz, C. Zubrod, 1977, National Cancer Institute monograph.

Screening data from the cancer chemotherapy National Service Center Screening Laboratories. XLV.

S. Schepartz, B. Abbott, J. Leiter, 1967, Cancer research.